RLAY Q1 2023 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$226,000-46.1% YoY

Gross Profit

-$83M-36549.1% margin

Operating Income

-$101M-44768.6% margin

Net Income

-$94M-41698.7% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

-10.7%

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$69M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$154M

Stockholders' Equity

$883M

Cash & Equivalents

$161M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$226,000	$419,000	-46.1%
Gross Profit	-$83M	-$51M	-61.2%
Operating Income	-$101M	-$63M	-61.3%
Net Income	-$94M	-$62M	-51.9%